glp 1 for diabetes GLP-1 Agonists: A Comprehensive Overview Glucagon-Like Peptide-1 Based Therapies: A

GLP-1 receptor agonists may be considered when additional treatment goals include weight reduction, improved glycemic control, chronic kidney disease risk reduction, or lowering atherosclerotic cardiovascular risk, particularly in patients with obesity or established Atherosclerotic Cardiovascular Disease (ASCVD) [7, 16, 47]

I was upset that my body was broken and that I needed to inject myself for the rest of my life

The peptide is structurally distinct from endogenous growth factors and does not share homology with any known human regulatory peptide outside its parent BPC sequence

(1984) successfully treated withdrawal symptoms in opiate- and alcohol-dependent patients (PMID: 6548969)